These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neoadjuvant chemotherapy in deeply invasive bladder cancer: the Italian experience. The Lombard Urologists. Semin Urol; 1990 Aug; 8(3):205-9. PubMed ID: 2204982 [No Abstract] [Full Text] [Related]
3. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder. Simon SD; Srougi M Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415 [No Abstract] [Full Text] [Related]
4. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder. Keating JP; Zincke H; Hahn RG; Morgan WR Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409 [No Abstract] [Full Text] [Related]
5. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
6. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract. Koch MO; Coussens D Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122 [No Abstract] [Full Text] [Related]
7. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study]. Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group. Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422 [No Abstract] [Full Text] [Related]
9. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. Freiha F; Reese J; Torti FM J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only. de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076 [TBL] [Abstract][Full Text] [Related]
11. Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080). Crawford ED; Natale RB; Burton H Prog Clin Biol Res; 1990; 353():111-3. PubMed ID: 2217407 [No Abstract] [Full Text] [Related]